Capital World Investors’s 10x Genomics TXG Stock Holding History

Capital World Investors’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$57.2M	Buy	1,493,031 +40,731	+3%	+$1.07M	0.01%	473
2026 Q1	$30.8M	Hold	1,452,300	–	–	﹤0.01%	506
2025 Q4	$23.7M	Hold	1,452,300	–	–	﹤0.01%	475
2025 Q3	$17M	Hold	1,452,300	–	–	﹤0.01%	485
2025 Q2	$16.8M	Hold	1,452,300	–	–	﹤0.01%	480
2025 Q1	$12.7M	Buy	1,452,300 +659,000	+83%	+$8.31M	﹤0.01%	477
2024 Q4	$11.4M	Hold	793,300	–	–	﹤0.01%	477
2024 Q3	$17.9M	Hold	793,300	–	–	﹤0.01%	455
2024 Q2	$15.4M	Hold	793,300	–	–	﹤0.01%	458
2024 Q1	$29.8M	Hold	793,300	–	–	﹤0.01%	431
2023 Q4	$44.4M	Hold	793,300	–	–	0.01%	394
2023 Q3	$32.7M	Hold	793,300	–	–	0.01%	407
2023 Q2	$44.3M	Hold	793,300	–	–	0.01%	378
2023 Q1	$44.3M	Hold	793,300	–	–	0.01%	378
2022 Q4	$28.9M	Hold	793,300	–	–	0.01%	426
2022 Q3	$22.6M	Sell	793,300 -73,400	-8%	-$2.8M	0.01%	452
2022 Q2	$39.2M	Buy	+866,700	New	+$45M	0.01%	410
2020 Q4	–	Sell	-1,276,870	Closed	-$159M	–	579
2020 Q3	$159M	Buy	1,276,870 +1,132	+0.1%	+$119K	0.03%	286
2020 Q2	$114M	Buy	+1,275,738	New	+$99.4M	0.03%	297
2020 Q1	–	Sell	-150,000	Closed	-$11.4M	–	551
2019 Q4	$11.4M	Hold	150,000	–	–	﹤0.01%	457
2019 Q3	$7.56M	Buy	+150,000	New	+$8.3M	﹤0.01%	484

Other funds holding TXG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Capital World Investors's TXG Position: Q2 2026 in Review

Capital World Investors increased its 10x Genomics (TXG) stake by 2.8% in Q2 2026, buying an estimated $1.07M and bringing the position to 1,493,031 shares worth $57.2M. The position accounts for 0.01% of the portfolio, ranked #473.

Capital World Investors first reported a position in TXG in Q3 2019 and has held it in 21 quarters since. The position peaked at $159M in Q3 2020. 284 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Capital World Investors held 1,493,031 shares of 10x Genomics worth $57.2M as of Q2 2026.
Capital World Investors bought 40,731 10x Genomics shares in Q2 2026, an estimated $1.07M.
10x Genomics made up 0.01% of Capital World Investors's portfolio in Q2 2026, its #473 holding.
Capital World Investors first reported a position in 10x Genomics in Q3 2019 and has held it in 21 quarters since.
Capital World Investors's 10x Genomics position peaked at $159M in Q3 2020.
284 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.